Lorraine Spector

Array ( [id] => 4042093 [patent_doc_number] => 05968501 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Hepatocyte growth factor--induced proliferation and differentiation of erythroid cells' [patent_app_type] => 1 [patent_app_number] => 8/836896 [patent_app_country] => US [patent_app_date] => 1997-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5298 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968501.pdf [firstpage_image] =>[orig_patent_app_number] => 836896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1387278 [patent_doc_number] => 06552181 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Basal cell carcinoma tumor supressor gene' [patent_app_type] => B1 [patent_app_number] => 08/857636 [patent_app_country] => US [patent_app_date] => 1997-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 18 [patent_no_of_words] => 42212 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552181.pdf [firstpage_image] =>[orig_patent_app_number] => 08857636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804869 [patent_doc_number] => 05854022 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Polynucleotides encoding a CD53-like transmembrane protein' [patent_app_type] => 1 [patent_app_number] => 8/855140 [patent_app_country] => US [patent_app_date] => 1997-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 17732 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854022.pdf [firstpage_image] =>[orig_patent_app_number] => 855140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4223144 [patent_doc_number] => 06011003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'FLT-4(FMS-like tyrosine kinase), FLT-15, variants thereof used as growth factor inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/750141 [patent_app_country] => US [patent_app_date] => 1997-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 5 [patent_no_of_words] => 7937 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/011/06011003.pdf [firstpage_image] =>[orig_patent_app_number] => 750141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4319021 [patent_doc_number] => 06331301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Antibodies specific for vascular endothelial growth factor-B' [patent_app_type] => 1 [patent_app_number] => 8/851896 [patent_app_country] => US [patent_app_date] => 1997-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 30 [patent_no_of_words] => 21334 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331301.pdf [firstpage_image] =>[orig_patent_app_number] => 851896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4092213 [patent_doc_number] => 06133434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Purinergic receptor' [patent_app_type] => 1 [patent_app_number] => 8/842079 [patent_app_country] => US [patent_app_date] => 1997-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 47 [patent_no_of_words] => 15556 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133434.pdf [firstpage_image] =>[orig_patent_app_number] => 842079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3922974 [patent_doc_number] => 05945303 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Human hematopoietic-specific protein' [patent_app_type] => 1 [patent_app_number] => 8/837029 [patent_app_country] => US [patent_app_date] => 1997-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 20090 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945303.pdf [firstpage_image] =>[orig_patent_app_number] => 837029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992119 [patent_doc_number] => 05919657 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Nucleic acids encoding human thioredoxin protein; related reagents' [patent_app_type] => 1 [patent_app_number] => 8/826910 [patent_app_country] => US [patent_app_date] => 1997-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17624 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919657.pdf [firstpage_image] =>[orig_patent_app_number] => 826910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096512 [patent_doc_number] => 06066318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors' [patent_app_type] => 1 [patent_app_number] => 8/835162 [patent_app_country] => US [patent_app_date] => 1997-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 140514 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 319 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066318.pdf [firstpage_image] =>[orig_patent_app_number] => 835162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3942036 [patent_doc_number] => 05976835 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Nucleic acids encoding receptor recognition factor Stat1.alpha. and Stat1.beta., and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/820754 [patent_app_country] => US [patent_app_date] => 1997-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 53 [patent_no_of_words] => 47689 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976835.pdf [firstpage_image] =>[orig_patent_app_number] => 820754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404748 [patent_doc_number] => 06171828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Method for culturing microorganisms having a methanol metabolic pathway' [patent_app_type] => 1 [patent_app_number] => 8/811024 [patent_app_country] => US [patent_app_date] => 1997-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11076 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171828.pdf [firstpage_image] =>[orig_patent_app_number] => 811024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3980803 [patent_doc_number] => 05958737 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Single-chain .beta. subunit dimers of the glycoprotein hormones and recombinant materials related thereto' [patent_app_type] => 1 [patent_app_number] => 8/806772 [patent_app_country] => US [patent_app_date] => 1997-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10999 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958737.pdf [firstpage_image] =>[orig_patent_app_number] => 806772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3847162 [patent_doc_number] => 05766860 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Screening method using a recombinant kinase insert domain containing receptor and gene encoding same' [patent_app_type] => 1 [patent_app_number] => 8/810116 [patent_app_country] => US [patent_app_date] => 1997-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 29 [patent_no_of_words] => 9677 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766860.pdf [firstpage_image] =>[orig_patent_app_number] => 810116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4245428 [patent_doc_number] => 06221627 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor' [patent_app_type] => 1 [patent_app_number] => 8/806263 [patent_app_country] => US [patent_app_date] => 1997-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 9027 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221627.pdf [firstpage_image] =>[orig_patent_app_number] => 806263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4413818 [patent_doc_number] => 06193972 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Hybrid heterodimeric protein hormone' [patent_app_type] => 1 [patent_app_number] => 8/804166 [patent_app_country] => US [patent_app_date] => 1997-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 9 [patent_no_of_words] => 8905 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/193/06193972.pdf [firstpage_image] =>[orig_patent_app_number] => 804166 [rel_patent_id] =>[rel_patent_doc_number] =>)